Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy
Clinical trial NCT01894451 · COMPLETED
Trial details
- NCT number
- NCT01894451
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2017-03-17
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.